Novel approach to creating sustainable packaging from rice husks
.png)
Researchers have created a new approach to the designing of eco-friendly nanofibres extracted from rice husks, addressing the critical need for sustainable packaging materials in food and biopharmaceutical products.
A team of researchers, led by YoungHoon Jung and HyeJee Kang from Kyungpook National University, have demonstrated a novel method of creating chitosan-based composite films utilising nanofibres extracted from rice husks. The method highlighted in their research is notable for its usage of an agricultural waste product in the production of a potential packaging material, promoting circular economic practices.
The process involves a chemical pretreatment of rice husks and enzymatic hydrolysis during a biorefinery process. This produces lignin-rich lignocellulose nanofibres. These nanofibres offer unique hydrophobic properties and strength. When incorporated into chitosan and formed into composite films, the material gives enhanced mechanical and structural integrity. By repurposing what would be a waste product, this process contributes to overall waste reduction and marks a step forward for sustainable resource management. Moreover, the controllable process developed by the researchers may also allow for customised film formation, increasing economic feasibility for the biomaterials industry.
Establishing a circular economy within the pharmaceutical supply chain has dominated talks around sustainability, with particular attention towards pharmaceutical packaging. The need for sustainable primary and secondary pharmaceutical packaging often present challenges related to scaling supply chain operations and safety and efficacy preservation of the drug products. This process demonstrates an innovative approach towards sustainable material development in tandem with the feasibility of creating composite films from waste products. For the pharmaceutical packaging sector, these composite films also offer unique UV-blocking properties, highlighting potential usage in pharmaceutical and biomedical device packaging. The lead researchers emphasised the significance of the study and innovative development method in paving the way forward for greener biomaterial packaging for food and pharma.
Sources:
1. Rice husk can be used as a promising sustainable packaging material [Accessed March 27, 2024] https://www.eurekalert.org/news-releases/1039048
2. Kang HJ, Lee YJ, Lee JK et al. Production of Chitosan-Based Composite Film Reinforced with Lignin-Rich Lignocellulose Nanofibres from Rice Husk, J. Bioresour. Bioprod. Published online 15 March 2024. doi: 10.1016/j.jobab.2024.03.002
3. The CPO Starter Pack: Why and When to Bring in a Contract Packaging Partner [Accessed March 27, 2024] https://www.cphi-online.com/the-cpo-starter-pack-why-and-when-to-bring-in-a-news120889.html
Related News
-
News CPHI Americas 2025 - From the Floor
Our From the Floor live blog is back in Philadelphia for this year’s CPHI, this time under the new name CPHI Americas to embrace and represent the whole of the pharmaceutical supply chain from north to south.
-
News Women in Pharma: Unlocking patient inclusion at CPHI Americas
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can towards making the healthcare industry and workplace more equitable and inclusive.&nbs... -
News Tracking Innovation with Thermo Fisher Scientific: CPHI Americas Track Sponsor interview
As we gear up for CPHI Americas from May 20-22, 2025 at the Philadelphia Convention Center, we sat down with Track Sponsor Thermo Fisher Scientific to discuss the future of bioproduction in pharma.
-
News Welcome back to the CPHI Exhibitor Spotlight!
We’re continuing our journey through the standout companies heading to CPHI Americas 2025, and next up is Adare - a global leader known for turning complex formulation challenges into innovative, patient-centric solutions.
-
News PhRMA trade association issues comments on Section 232 investigation
The Pharmaceutical Research and Manufacturers of America (PhRMA), an American trade association representing groups in the pharmaceutical industry, issued a letter on May 6, 2026 to the Department of Commerce regarding the Section 232 National Security... -
News Pharmaceutical Packaging Market Prospects: Shifting regional policies
The pharmaceutical packaging industry is experiencing significant transformation in 2025, driven by regulatory changes, supply chain challenges, and sustainability initiatives. The US BIOSECURE Act, passed through the House of Representatives in Septem... -
News Executive order to elevate US pharma manufacturing signed by Trump
On Monday, May 5, US President Trump signed an executive order to reduce regulatory barriers for domestic US pharmaceutical manufacturing, including key ingredients and materials for manufacturing prescription drugs.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.